Variant report
Variant | nsv971691 |
---|---|
Chromosome Location | chr8:104779059-104781160 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:11)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:11 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MAFF | chr8:104780195-104780338 | K562 | blood: | n/a | chr8:104780251-104780269 |
2 | MAFF | chr8:104780129-104780709 | HepG2 | liver: | n/a | chr8:104780251-104780269 |
3 | MAFK | chr8:104780546-104780559 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | MAFK | chr8:104780099-104780749 | HepG2 | liver: | n/a | chr8:104780252-104780267 |
5 | MAFK | chr8:104780099-104780746 | HepG2 | liver: | n/a | chr8:104780252-104780267 |
6 | MAFK | chr8:104780234-104780269 | K562 | blood: | n/a | chr8:104780252-104780267 |
7 | MAFK | chr8:104780172-104780658 | IMR90 | lung: | n/a | chr8:104780252-104780267 |
8 | POLR2A | chr8:104780667-104780852 | GM12878 | blood: | n/a | n/a |
9 | POLR2A | chr8:104780601-104780880 | GM12878 | blood: | n/a | n/a |
10 | POLR2A | chr8:104780690-104780783 | GM12878 | blood: | n/a | n/a |
11 | STAT3 | chr8:104779819-104780002 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:104776048..104778695-chr8:104778794..104781400,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000239344 | TF binding region |
ENSG00000176406 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75927984 | chr8:104779105-104779106 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs146448832 | chr8:104779154-104779155 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs75863089 | chr8:104779157-104779158 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs560301168 | chr8:104779158-104779159 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs527655172 | chr8:104779199-104779200 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs546605739 | chr8:104779222-104779223 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs545075382 | chr8:104779223-104779224 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs571510852 | chr8:104779258-104779259 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs558026792 | chr8:104779272-104779273 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs76748835 | chr8:104779303-104779304 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | mRNA abundance |
11 | rs373582178 | chr8:104779304-104779305 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs550799018 | chr8:104779321-104779322 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs75363139 | chr8:104779362-104779363 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | mRNA abundance |
14 | rs3110460 | chr8:104779368-104779369 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs529119351 | chr8:104779393-104779394 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs185243921 | chr8:104779394-104779395 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs35159105 | chr8:104779421-104779422 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs533764522 | chr8:104779443-104779444 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs559025932 | chr8:104779447-104779448 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs13273605 | chr8:104779478-104779479 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs544454915 | chr8:104779500-104779501 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs117960640 | chr8:104779508-104779509 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs189996782 | chr8:104779518-104779519 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs541940971 | chr8:104779541-104779542 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs547944375 | chr8:104779571-104779572 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs375188186 | chr8:104779611-104779612 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs560612380 | chr8:104779618-104779619 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs183350289 | chr8:104779702-104779703 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs143339673 | chr8:104779705-104779706 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs375233799 | chr8:104779708-104779709 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs73291826 | chr8:104779713-104779714 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs550862131 | chr8:104779722-104779723 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs369493494 | chr8:104779782-104779783 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs531334548 | chr8:104779826-104779827 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs73291828 | chr8:104779830-104779831 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs187189744 | chr8:104779914-104779915 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs548016683 | chr8:104779930-104779931 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs572410282 | chr8:104779948-104779949 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs566549893 | chr8:104779959-104779960 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs533596946 | chr8:104780091-104780092 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs551130907 | chr8:104780110-104780111 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs191668887 | chr8:104780118-104780119 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs183491779 | chr8:104780141-104780142 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs369545567 | chr8:104780155-104780156 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs556412299 | chr8:104780198-104780199 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs188146485 | chr8:104780199-104780200 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs568171440 | chr8:104780236-104780237 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs147582338 | chr8:104780250-104780251 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs190048011 | chr8:104780253-104780254 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs182683098 | chr8:104780280-104780281 | Weak transcription Strong transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Breast cancer | 20409316 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Oral squamous cell carcinoma | 21853135 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Prostate cancer | 22341455 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:104757000-104780400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr8:104770200-104784000 | Weak transcription | H1 Cell Line | embryonic stem cell |
3 | chr8:104773000-104781800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr8:104773000-104782400 | Weak transcription | Adipose Nuclei | Adipose |
5 | chr8:104773600-104784800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr8:104775000-104780600 | Weak transcription | H9 Cell Line | embryonic stem cell |
7 | chr8:104775200-104780600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
8 | chr8:104775200-104781800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr8:104775400-104780800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
10 | chr8:104777400-104780600 | Enhancers | Primary monocytes fromperipheralblood | blood |
11 | chr8:104777400-104780600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
12 | chr8:104778400-104779200 | Strong transcription | HUES48 Cell Line | embryonic stem cell |
13 | chr8:104778400-104779200 | Strong transcription | HUES6 Cell Line | embryonic stem cell |
14 | chr8:104778400-104779200 | Strong transcription | iPS-20b Cell Line | embryonic stem cell |
15 | chr8:104778400-104782200 | Strong transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr8:104778600-104779200 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr8:104778600-104779200 | Strong transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
18 | chr8:104779200-104780800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
19 | chr8:104779200-104782600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr8:104779200-104783000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
21 | chr8:104779200-104788400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
22 | chr8:104779200-104801200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
23 | chr8:104780600-104780800 | Enhancers | H9 Cell Line | embryonic stem cell |
24 | chr8:104780800-104781000 | Weak transcription | H9 Cell Line | embryonic stem cell |